Table 3.

Proteins with differential abundance in schizophrenia reported as characteristic of individual cell types by transcriptional studies of mouse brain cells and mononuclear cells.

Gene	Cell type	Descriptive Group*	Citations**
ALDOC	astrocytes	C: 13/40; C: well-described; C: astrocyte-enriched	Martins-de-Souza et al., 2009d	Novikova et al., 2006	Johnston-Wilson et al., 2000	English et al., 2009	Martins-de-Souza et al., 2009a	Prabakaran et al., 2004	Smalla et al., 2008	Clark et al., 2006	Clark et al., 2007	Martins-de-Souza et al., 2009b	Martins-De-Souza et al., 2010c
GFAP	astrocytes	C: 13/40; C: well-described; C: astrocyte-enriched	Martins-de-Souza et al., 2009d	Martins-de-Souza et al., 2010a	Johnston-Wilson et al., 2000	Martins-de-Souza et al., 2009a	Pennington et al., 2008	Clark et al., 2006	Sivagnanasundaram et al., 2007	Martins-de-Souza et al., 2009b	Föcking et al., 2011
HIST1H3G	astrocytes	C: developmental	Martins-de-Souza et al., 2009d
HSPA1B	astrocytes	C: developmental	Nesvaderani et al., 2009
PDE8B	astrocytes	C: developmental	English et al., 2009
PYGM	astrocytes	C: developmental	Saia-Cereda et al., 2015
SLC9A3R1	astrocytes	C: astrocyte-enriched	Martins-de-Souza et al., 2009d
GNAQ	microglia	Y: MG-enriched	Smalla et al., 2008
MAPK3	microglia	Y: MG-enriched	Martins-de-Souza et al., 2010b
GAPDH	monocytes	Y: monocyte-enriched	Martins-de-Souza et al., 2009c	Martins-de-Souza et al., 2010a	Saia-Cereda et al., 2015	Martins-de-Souza et al., 2009b
PGK1	monocytes	Y: monocyte-enriched	Martins-de-Souza et al., 2009a
NEFL	neurons	C: well-described; C: neuron-enriched	Martins-de-Souza et al., 2009d	English et al., 2009	Martins-de-Souza et al., 2009a	Pennington et al., 2008	Clark et al., 2007	Saia-Cereda et al., 2015	Sivagnanasundaram et al., 2007	Föcking et al., 2011
NEFM	neurons	C: neuron-enriched	Martins-de-Souza et al., 2009d	Martins-de-Souza et al., 2010a	English et al., 2009	Saia-Cereda et al., 2015	Sivagnanasundaram et al., 2007	Nesvaderani et al., 2009
CAMK2B	neurons	C: neuron-enriched	Martins-de-Souza et al., 2010b
GDA	neurons	C: 29/40; C: neuron-enriched	Pennington et al., 2008
CNP	oligodendrocytes	C: oligodendrocyte-enriched	Martins-de-Souza et al., 2009c	Martins-de-Souza et al., 2009d	Prabakaran et al., 2004	Saia-Cereda et al., 2015
MBP	oligodendrocytes	C: 27/40; C: well-described; C: oligodendrocyte-enriched C:developmental	Martins-de-Souza et al., 2009d	Martins-de-Souza et al., 2010a	Martins-de-Souza et al., 2009a	Saia-Cereda et al., 2015
MOG	oligodendrocytes	C: 2/40; C: well-described; C: oligodendrocyte-enriched; C: developmental	Martins-de-Souza et al., 2009c	Martins-de-Souza et al., 2009d	Martins-de-Souza et al., 2010a	Saia-Cereda et al., 2015
GSN	oligodendrocytes	C: 10/40; C: oligodendrocyte-enriched	Prabakaran et al., 2004	Saia-Cereda et al., 2015	Nesvaderani et al., 2009
HAPLN2	oligodendrocytes	C: oligodendrocyte-enriched; C:developmental	Saia-Cereda et al., 2015
MYO1D	oligodendrocytes	C: oligodendrocyte-enriched; C:developmental	Martins-de-Souza et al., 2009c
PLP1	oligodendrocytes	C: 17/40; C: oligodendrocyte-enriched; C:developmental	English et al., 2009

^*Descriptive Group refers to the heading of the table(s) from Cahoy et al. (2008) (C) or Yamasaki et al. (2014) (Y) in which the gene was listed.

[Number]/40 refers to the rank on the list of “Top 40” genes for that cell type.

^**Citations are the references for proteomic studies reporting that the protein is altered in schizophrenia.